General issues related to patent protections.
2025 · 1st Quarter (Jan 1 - Mar 31)
NOVO NORDISK INC.
Filed by WILLIAMS AND JENSEN, PLLC.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 21, 2025
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- WILLIAMS AND JENSEN, PLLC
- Client
- NOVO NORDISK INC.
- Filing UUID
- 4adeca26-42df-4b19-aeb2-84e46b4b12e8
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Treat and Reduce Obesity Act and obesity treatment in COVID-19 relief; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. Public Law 118-47. American Relief Act (P.L. 118-158).
Support for obesity drug coverage and access.
Treat and Reduce Obesity Act and obesity treatment in COVID-19 relief; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. Public Law 118-47. American Relief Act (P.L. 118-158).
Issues related to corporate tax and international tax.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.